Esperion Therapeutics (0IIM.LSE) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.5
-0.22
0.06
0.34

Details

Expected EPS
-0.172143
Actual EPS
-0.33
Surprise EPS
-0.16
Surprise Percent
+91.7%

Description

Esperion Therapeutics (0IIM.LSE) has reported earnings of -0.33 per share for Q3 2024.

0 Comments

Share your thoughts